KeyBank National Association’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-12,548
Closed -$306K 1109
2017
Q4
$306K Sell
12,548
-11,188
-47% -$215K ﹤0.01% 887
2017
Q3
$438K Sell
23,736
-8,858
-27% -$153K ﹤0.01% 820
2017
Q2
$540K Buy
32,594
+3,235
+11% +$45K ﹤0.01% 792
2017
Q1
$405K Buy
29,359
+4,721
+19% +$75.8K ﹤0.01% 880
2016
Q4
$467K Hold
24,638
﹤0.01% 835
2016
Q3
$546K Buy
24,638
+5,157
+26% +$96.9K ﹤0.01% 795
2016
Q2
$356K Hold
19,481
﹤0.01% 894
2016
Q1
$354K Hold
19,481
﹤0.01% 886
2015
Q4
$328K Buy
19,481
+6,085
+45% +$103K ﹤0.01% 926
2015
Q3
$241K Buy
13,396
+3,291
+33% +$73.3K ﹤0.01% 1014
2015
Q2
$261K Buy
+10,105
New +$255K ﹤0.01% 1053

KeyBank National Association's ENTL Position: Q1 2018 in Review

KeyBank National Association sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 12,548 shares — an estimated $306K sold.

KeyBank National Association first reported a position in ENTL in Q2 2015 and held it in 11 quarters. The position peaked at $546K in Q3 2016. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

  • KeyBank National Association reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • KeyBank National Association sold 12,548 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $306K.
  • KeyBank National Association first reported a position in Entellus Medical, Inc. Common Stock in Q2 2015 and held it in 11 quarters.
  • KeyBank National Association's Entellus Medical, Inc. Common Stock position peaked at $546K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on KeyBank National Association's 13F filing for Q1 2018, filed 15 May 2018.